Metamizol	metamizol	S_chemical	O
potentiates	potentiates	O	O
morphine	morphine	S_chemical	O
antinociception	antinociception	O	O
but	but	O	O
not	not	O	O
constipation	constipation	O	S_disease
after	after	O	O
chronic	chronic	O	O
treatment	treatment	O	O
.	.	O	O

This	this	O	O
work	work	O	O
evaluates	evaluates	O	O
the	the	O	O
antinociceptive	antinociceptive	O	O
and	and	O	O
constipating	constipating	O	O
effects	effects	O	O
of	of	O	O
the	the	O	O
combination	combination	O	O
of	of	O	O
3.2	3.2	O	O
mg/kg	mg/kg	O	O
s.c	s.c	O	O
.	.	O	O

morphine	morphine	S_chemical	O
with	with	O	O
177.8	177.8	O	O
mg/kg	mg/kg	O	O
s.c	s.c	O	O
.	.	O	O

metamizol	metamizol	S_chemical	O
in	in	O	O
acutely	acutely	O	O
and	and	O	O
chronically	chronically	O	O
treated	treated	O	O
(	(	O	O
once	once	O	O
a	a	O	O
day	day	O	O
for	for	O	O
12	12	O	O
days	days	O	O
)	)	O	O
rats	rats	O	O
.	.	O	O

On	on	O	O
the	the	O	O
13th	13th	O	O
day	day	O	O
,	,	O	O
antinociceptive	antinociceptive	O	O
effects	effects	O	O
were	were	O	O
assessed	assessed	O	O
using	using	O	O
a	a	O	O
model	model	O	O
of	of	O	O
inflammatory	inflammatory	O	O
nociception	nociception	O	O
,	,	O	O
pain-induced	pain-induced	O	O
functional	functional	O	B_disease
impairment	impairment	O	I_disease
model	model	O	O
,	,	O	O
and	and	O	O
the	the	O	O
charcoal	charcoal	O	O
meal	meal	O	O
test	test	O	O
was	was	O	O
used	used	O	O
to	to	O	O
evaluate	evaluate	O	O
the	the	O	O
intestinal	intestinal	O	O
transit	transit	O	O
.	.	O	O

Simultaneous	simultaneous	O	O
administration	administration	O	O
of	of	O	O
morphine	morphine	S_chemical	O
with	with	O	O
metamizol	metamizol	S_chemical	O
resulted	resulted	O	O
in	in	O	O
a	a	O	O
markedly	markedly	O	O
antinociceptive	antinociceptive	O	O
potentiation	potentiation	O	O
and	and	O	O
an	an	O	O
increasing	increasing	O	O
of	of	O	O
the	the	O	O
duration	duration	O	O
of	of	O	O
action	action	O	O
after	after	O	O
a	a	O	O
single	single	O	O
(	(	O	O
298+/-7	298+/-7	O	O
vs.	vs.	O	O
139+/-36	139+/-36	O	O
units	units	O	O
area	area	O	O
(	(	O	O
ua	ua	O	O
)	)	O	O
;	;	O	O
P<0.001	p<0.001	O	O
)	)	O	O
and	and	O	O
repeated	repeated	O	O
administration	administration	O	O
(	(	O	O
280+/-17	280+/-17	O	O
vs.	vs.	O	O
131+/-22	131+/-22	O	O
ua	ua	O	O
;	;	O	O
P<0.001	p<0.001	O	O
)	)	O	O
.	.	O	O

Antinociceptive	antinociceptive	O	O
effect	effect	O	O
of	of	O	O
morphine	morphine	S_chemical	O
was	was	O	O
reduced	reduced	O	O
in	in	O	O
chronically	chronically	O	O
treated	treated	O	O
rats	rats	O	O
(	(	O	O
39+/-10	39+/-10	O	O
vs.	vs.	O	O
18+/-5	18+/-5	O	O
au	au	O	O
)	)	O	O
while	while	O	O
the	the	O	O
combination-induced	combination-induced	O	O
antinociception	antinociception	O	O
was	was	O	O
remained	remained	O	O
similar	similar	O	O
as	as	O	O
an	an	O	O
acute	acute	O	O
treatment	treatment	O	O
(	(	O	O
298+/-7	298+/-7	O	O
vs.	vs.	O	O
280+/-17	280+/-17	O	O
au	au	O	O
)	)	O	O
.	.	O	O

Acute	acute	O	O
antinociceptive	antinociceptive	O	O
effects	effects	O	O
of	of	O	O
the	the	O	O
combination	combination	O	O
were	were	O	O
partially	partially	O	O
prevented	prevented	O	O
by	by	O	O
3.2	3.2	O	O
mg/kg	mg/kg	O	O
naloxone	naloxone	S_chemical	O
s.c	s.c	O	O
.	.	O	O
(	(	O	O
P<0.05	p<0.05	O	O
)	)	O	O
,	,	O	O
suggesting	suggesting	O	O
the	the	O	O
partial	partial	O	O
involvement	involvement	O	O
of	of	O	O
the	the	O	O
opioidergic	opioidergic	O	O
system	system	O	O
in	in	O	O
the	the	O	O
synergism	synergism	O	O
observed	observed	O	O
.	.	O	O

In	in	O	O
independent	independent	O	O
groups	groups	O	O
,	,	O	O
morphine	morphine	S_chemical	O
inhibited	inhibited	O	O
the	the	O	O
intestinal	intestinal	O	O
transit	transit	O	O
in	in	O	O
48+/-4	48+/-4	O	O
%	%	O	O
and	and	O	O
38+/-4	38+/-4	O	O
%	%	O	O
after	after	O	O
acute	acute	O	O
and	and	O	O
chronic	chronic	O	O
treatment	treatment	O	O
,	,	O	O
respectively	respectively	O	O
,	,	O	O
suggesting	suggesting	O	O
that	that	O	O
tolerance	tolerance	O	O
did	did	O	O
not	not	O	O
develop	develop	O	O
to	to	O	O
the	the	O	O
constipating	constipating	O	O
effects	effects	O	O
.	.	O	O

The	the	O	O
combination	combination	O	O
inhibited	inhibited	O	O
intestinal	intestinal	O	O
transit	transit	O	O
similar	similar	O	O
to	to	O	O
that	that	O	O
produced	produced	O	O
by	by	O	O
morphine	morphine	S_chemical	O
regardless	regardless	O	O
of	of	O	O
the	the	O	O
time	time	O	O
of	of	O	O
treatment	treatment	O	O
,	,	O	O
suggesting	suggesting	O	O
that	that	O	O
metamizol	metamizol	S_chemical	O
did	did	O	O
not	not	O	O
potentiate	potentiate	O	O
morphine-induced	morphine-induced	O	O
constipation	constipation	O	S_disease
.	.	O	O

These	these	O	O
findings	findings	O	O
show	show	O	O
a	a	O	O
significant	significant	O	O
interaction	interaction	O	O
between	between	O	O
morphine	morphine	S_chemical	O
and	and	O	O
metamizol	metamizol	S_chemical	O
in	in	O	O
chronically	chronically	O	O
treated	treated	O	O
rats	rats	O	O
,	,	O	O
suggesting	suggesting	O	O
that	that	O	O
this	this	O	O
combination	combination	O	O
could	could	O	O
be	be	O	O
useful	useful	O	O
for	for	O	O
the	the	O	O
treatment	treatment	O	O
of	of	O	O
chronic	chronic	O	B_disease
pain	pain	O	S_disease
.	.	O	O

